SYNERGY PHARMACEUTICALS INC DEL Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SGYPQ and buy or sell other stocks, ETFs, and their options commission-free!About SGYPQ
Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation.
CEOGary S. Jacob, PhD
CEOGary S. Jacob, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
SGYPQ Key Statistics
Market cap1.59M
Market cap1.59M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume1.60M
Average volume1.60M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.10
52 Week high$2.10
52 Week low$0.005
52 Week low$0.005
Stock Snapshot
With a market cap of 1.59M, SYNERGY PHARMACEUTICALS INC DEL Common Stock(SGYPQ) trades at $0.01. The stock has a price-to-earnings ratio of -0.01.
SYNERGY PHARMACEUTICALS INC DEL Common Stock(SGYPQ) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
SYNERGY PHARMACEUTICALS INC DEL Common Stock(SGYPQ) shares are trading with a volume of 0, against a daily average of 1.6M.
In the last year, SYNERGY PHARMACEUTICALS INC DEL Common Stock(SGYPQ) shares hit a 52-week high of $2.10 and a 52-week low of $0.01.
In the last year, SYNERGY PHARMACEUTICALS INC DEL Common Stock(SGYPQ) shares hit a 52-week high of $2.10 and a 52-week low of $0.01.